Stem Cell Research (May 2022)

Generation of an integration-free induced pluripotent stem cell line (LZUSHI001-A) from an epileptic patient with DGKG mutation

  • Ya-Qing Liu,
  • Tiao-Wen Ling,
  • Hong-Yan Wang,
  • Yan-Hong Yang,
  • Wen-jun Song,
  • Tian-Cheng Wang

Journal volume & issue
Vol. 61
p. 102768

Abstract

Read online

Epilepsy is a common chronic neurological disorder related to genetic factors. Base on the non-integrating episomal vector technique, a human induced pluripotent stem cell (iPSC) line, termed as LZUSHI001-A, was generated from peripheral blood mononuclear cells (PBMCs) of a 11-year-old male patient with Epilepsy, who had a heterozygous (c.2042G>A, p.R681Q) mutation in the DGKG gene. LZUSHI001-A offers a useful resource to investigate pathogenic mechanisms in epilepsy, as well as a cell-based model for drug development to treat epilepsy.